113 related articles for article (PubMed ID: 1516296)
1. Pregnancy outcome and infant development following gestational cocaine use by social cocaine users in Toronto, Canada.
Graham K; Feigenbaum A; Pastuszak A; Nulman I; Weksberg R; Einarson T; Goldberg S; Ashby S; Koren G
Clin Invest Med; 1992 Aug; 15(4):384-94. PubMed ID: 1516296
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy outcome following first trimester exposure to cocaine in social users in Toronto, Canada.
Graham K; Dimitrakoudis D; Pellegrini E; Koren G
Vet Hum Toxicol; 1989 Apr; 31(2):143-8. PubMed ID: 2929123
[TBL] [Abstract][Full Text] [Related]
3. Neurodevelopment of adopted children exposed in utero to cocaine.
Nulman I; Rovet J; Altmann D; Bradley C; Einarson T; Koren G
CMAJ; 1994 Dec; 151(11):1591-7. PubMed ID: 7954158
[TBL] [Abstract][Full Text] [Related]
4. Cocaine-exposed children: follow-up through 30 months.
Hurt H; Brodsky NL; Betancourt L; Braitman LE; Malmud E; Giannetta J
J Dev Behav Pediatr; 1995 Feb; 16(1):29-35. PubMed ID: 7730454
[TBL] [Abstract][Full Text] [Related]
5. Natal status of infants of cocaine users and control subjects: a prospective comparison.
Hurt H; Brodsky NL; Braitman LE; Giannetta J
J Perinatol; 1995; 15(4):297-304. PubMed ID: 8558338
[TBL] [Abstract][Full Text] [Related]
6. Polydrug-using adolescent mothers and their infants receiving early intervention.
Field TM; Scafidi F; Pickens J; Prodromidis M; Pelaez-Nogueras M; Torquati J; Wilcox H; Malphurs J; Schanberg S; Kuhn C
Adolescence; 1998; 33(129):117-43. PubMed ID: 9583666
[TBL] [Abstract][Full Text] [Related]
7. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age.
Vohr BR; Poindexter BB; Dusick AM; McKinley LT; Wright LL; Langer JC; Poole WK;
Pediatrics; 2006 Jul; 118(1):e115-23. PubMed ID: 16818526
[TBL] [Abstract][Full Text] [Related]
9. Intrauterine cocaine and crack exposure: neonatal outcome.
Datta-Bhutada S; Johnson HL; Rosen TS
J Perinatol; 1998; 18(3):183-8. PubMed ID: 9659645
[TBL] [Abstract][Full Text] [Related]
10. Relationship between gestational cocaine use and pregnancy outcome: a meta-analysis.
Lutiger B; Graham K; Einarson TR; Koren G
Teratology; 1991 Oct; 44(4):405-14. PubMed ID: 1835806
[TBL] [Abstract][Full Text] [Related]
11. Prenatal cocaine exposure and prolonged focus attention. Poor infant information processing ability or precocious maturation of attentional systems?
Chiriboga CA; Starr D; Kuhn L; Wasserman GA
Dev Neurosci; 2009; 31(1-2):149-58. PubMed ID: 19372695
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy outcome of women inadvertently exposed to ribostamycin during early pregnancy: a prospective cohort study.
Lee SW; Han JY; Choi JS; Chung JH; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
Reprod Toxicol; 2009 Apr; 27(2):196-8. PubMed ID: 19162171
[TBL] [Abstract][Full Text] [Related]
13. Neurodevelopment of adopted children exposed in utero to cocaine: the Toronto Adoption Study.
Nulman I; Rovet J; Greenbaum R; Loebstein M; Wolpin J; Pace-Asciak P; Koren G
Clin Invest Med; 2001 Jun; 24(3):129-37. PubMed ID: 11437064
[TBL] [Abstract][Full Text] [Related]
14. Neuromotor development of cocaine-exposed and control infants from birth through 15 months: poor and poorer performance.
Fetters L; Tronick EZ
Pediatrics; 1996 Nov; 98(5):938-43. PubMed ID: 8909489
[TBL] [Abstract][Full Text] [Related]
15. Motor and cognitive outcomes in nondisabled low-birth-weight adolescents: early determinants.
Whitaker AH; Feldman JF; Lorenz JM; Shen S; McNicholas F; Nieto M; McCulloch D; Pinto-Martin JA; Paneth N
Arch Pediatr Adolesc Med; 2006 Oct; 160(10):1040-6. PubMed ID: 17018463
[TBL] [Abstract][Full Text] [Related]
16. Prenatal cocaine/polydrug exposure: effect of race on outcome.
Billman DO; Nemeth PB; Heimler R; Sasidharan P
J Perinatol; 1996; 16(5):366-9. PubMed ID: 8915935
[TBL] [Abstract][Full Text] [Related]
17. A cohort study of alkaloidal cocaine ("crack") in pregnancy.
Cherukuri R; Minkoff H; Feldman J; Parekh A; Glass L
Obstet Gynecol; 1988 Aug; 72(2):147-51. PubMed ID: 3393357
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study.
Bar-Oz B; Moretti ME; Bishai R; Mareels G; Van Tittelboom T; Verspeelt J; Koren G
Am J Obstet Gynecol; 2000 Sep; 183(3):617-20. PubMed ID: 10992182
[TBL] [Abstract][Full Text] [Related]
19. Effects of prenatal cocaine exposure on growth: a longitudinal analysis.
Richardson GA; Goldschmidt L; Larkby C
Pediatrics; 2007 Oct; 120(4):e1017-27. PubMed ID: 17893189
[TBL] [Abstract][Full Text] [Related]
20. The cost of maternal cocaine abuse: I. Perinatal cost.
Calhoun BC; Watson PT
Obstet Gynecol; 1991 Nov; 78(5 Pt 1):731-4. PubMed ID: 1923187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
